Daxor Corp DXR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Daxor Accelerates Commercial Expansion of Next-Gen Blood Volume Diagnostic Platform at MedAxiom CV Transforum Fall '26
Daxor Announces Strong Commercial Interest and New Clinical Data at HFSA 2026
Daxor to Showcase Blood Volume Analysis Platform at ASN Kidney Week 2026
Daxor to Showcase Next-Gen Blood Volume Analyzer and New Clinical Data at HFSA 2026
Daxor Corporation to Participate in the 10th Annual Lake Street Best Ideas Growth Conference
Daxor Corporation CEO and President Michael Feldschuh Delivers 1st Half Corporate Update in Shareholder Letter
Trading Information
- Previous Close Price
- $8.63
- Day Range
- $8.56–8.61
- 52-Week Range
- $8.18–15.00
- Bid/Ask
- $8.31 / $8.69
- Shares Outstanding
- 5.84M
- Market Cap
- $50.38M
- Volume/Avg
- 928 / 20,846
Key Statistics
- Price/Earnings (Normalized)
- 8.22
- Price/Sales
- 5.21
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system. The company operates as a single business segment centered on the development, commercialization, and support of its proprietary blood volume analysis technology used by healthcare providers.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Growth
- Total Number of Employees
- 750
- Website
- https://www.daxor.com
Valuation
Metric | DXR |
|---|---|
Price/Earnings (Normalized) | 8.22 |
Price/Book Value | 0.97 |
Price/Sales | 5.21 |
Price/Cash Flow | — |
Price/Earnings
DXR
Financial Strength
Metric | DXR |
|---|---|
Quick Ratio | — |
Current Ratio | — |
Interest Coverage | — |
Quick Ratio
No chart available
Profitability
Metric | DXR |
|---|---|
Return on Assets (Normalized) | 13.97% |
Return on Equity (Normalized) | 14.01% |
Return on Invested Capital (Normalized) | — |
Return on Assets
DXR
Medical Instruments & Supplies Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc ISRG | LOCK|%!H@#dB | LOCK|?!M | $166B | |||
| Becton Dickinson & Co BDX | LOCK|G& | LOCK|Qq@! | $58B | |||
| Alcon Inc ALC | LOCK|TSWGl@ | LOCK|J%^!& | $37B | |||
| Medline Inc Ordinary Shares - Class A MDLN | LOCK|kq!#tR | LOCK|n>ZR | $35B | |||
| ResMed Inc RMD | LOCK|MtCt@$N | LOCK|QD&%H | $34B | |||
| West Pharmaceutical Services Inc WST | LOCK|G?&F#Vd | LOCK|D%% | $27B | |||
| Solventum Corp SOLV | LOCK|>vRj?s | LOCK|p#& | $15B | |||
| Baxter International Inc BAX | LOCK|Pb | LOCK|Fpg$w | $13B | |||
| The Cooper Companies Inc COO | LOCK|#F&>Y< | LOCK|KKrL | $12B | |||
| Align Technology Inc ALGN | LOCK|!%shLqs | LOCK|H%ds@ | $11B |
United States